Sanofi, DNDi to collaborate on neglected diseases; Renovo winds down; AZ and Heptares in development pact

@FierceBiotech: Rigel raises $130M for PhII trial of asthma drug. Article | Follow @FierceBiotech

@JohnCFierce: Lights out for Renovo as staff is let go and assets auctioned off. UK biotech done in by unsuccessful Ph3 for Juvista. News | Follow @JohnCFierce

> Sanofi and DNDi have forged a collaboration to develop new drugs for neglected diseases. Article

> With its lead program shuttered, Renovo is laying off staffers and selling off its remaining assets as the once promising UK biotech winds down operations. Story

> Oceana Therapeutics says that the FDA has approved Solesta, a new treatment for fecal incontinence. Release

> AstraZeneca and Heptares have forged a collaboration to study GPCR drugs. "This exciting collaboration gives us access to cutting-edge technology that will enable us to apply our biophysical and antibody generation capabilities to this important, yet extremely challenging, area of research," said Martin Mackay, head of research and development at AstraZeneca. Story

Pharma News

@FiercePharma: Abbott down after NIH halts Niaspan study. News | Follow @FiercePharma

> France to stop paying for Pfizer's Champix. News

> N. American pharma buys drive up M&A prices. Report

> Amarin taps suppliers for 'aggressive' launch. Item

Biotech IT News

> U. Maryland hooks up with OpGen on microbial database. Article

> 23andMe eyes Big Pharma for future growth. Report

> Just one word... bioinformatics. Story

> Oracle, others plan NY clinical research network. News

Biotech Research News

> Researchers help lab mice better reflect human genetic diversity. Article

> Carbon nanotube patch could regenerate heart tissue after attack. Report

> A gene gone wild may cause stomach cancer. News

> Researchers establish link between obesity, vitamin D levels. Report

> ViaCyte progresses toward trials in stem cell diabetes treatment. News

> Skin cells transformed directly into neurons. Story

Manufacturing News

> 11 plead guilty in fake Avastin case. Report

> India sees rise in post-vax deaths. Item

> Serialization slowly losing sleeper status. Article

> FDA posts inspection findings, common violations. Story

> BMS streamlines data matrix coding. Item

And Finally... University of Pittsburgh researchers have reproduced the brain's electrical impulses onto models made of living brain cells, offering an unprecedented view of the neuron activity behind memory formation. Release

Suggested Articles

Omega Therapeutics is working on treatments that adjust gene expression up or down without making permanent changes to the genome.

The IPO window is still wide open for biotech, and French Big Pharma-partnered Innate is looking to jump right on through.

Panelists at the CAR-TCR Summit reflected on gender diversity trends and the challenges women face in the life sciences industry.